Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001209191-16-156269

CEO and Director bought 69,000 shares at $2.20 ($151,662)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
MENDLEIN JOHN CEO and Director 2016-12-19 Purchase +69,000 $2.20 $151,662 324,971 D: show line 1 in the form
Open-market purchases · 69,000 sh · avg $2.20 · $151,662
Loading xslF345X03/doc4.xml…